Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118690 · ClinicalTrials.gov registry record · Phase 4
A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 227
- Enrollment target
NCT00118690 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 227 participants.
The verdict
NCT00118690, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 227 participants
- Enrollment target
Study Summary
During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history review, exercise challenge test (walking/running on a treadmill), electrocardiogram (ECG) tests, and lung function tests. All study related medications and medical examinations are provided at no cost. All study drugs are currently available by prescription to patients 4 years and older.
Interventions
- DRUG Fluticasone propionate/salmeterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00118690
The ClinicalTrials.gov registry entry for NCT00118690 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluticasone propionate/salmeterol is the first listed.
NCT00118690 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00118690 about?
NCT00118690 is a clinical study titled "A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise". During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history review, exercise challenge test (walking/running on a treadmill), electrocardiogram (ECG) tests, and lung...
What is the current status of trial NCT00118690?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 227 participants. The study started on 2003-12. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00118690?
The interventions under investigation include: Fluticasone propionate/salmeterol (DRUG).
Who is sponsoring clinical trial NCT00118690?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.